NDC 21695-366

CRIXIVAN

Indinavir Sulfate

CRIXIVAN is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Rebel Distributors Corp. The primary component is Indinavir Sulfate.

• Product ID: 21695-366_01c5574c-1056-49c6-af20-e950db3f4139
• NDC: 21695-366
• Product Type: Human Prescription Drug
• Proprietary Name: CRIXIVAN
• Generic Name: Indinavir Sulfate
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 1996-03-13
• Marketing Category: NDA / NDA
• Application Number: NDA020685
• Labeler Name: Rebel Distributors Corp
• Substance Name: INDINAVIR SULFATE
• Active Ingredient Strength: 400 mg/1
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 21695-366-18

18 CAPSULE in 1 BOTTLE (21695-366-18)

• Marketing Start Date: 1996-03-13
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 21695-366-18 [21695036618]

CRIXIVAN CAPSULE

• Marketing Category: NDA
• Application Number: NDA020685
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 1996-03-13
• Inactivation Date: 2019-09-24

Drug Details

Active Ingredients

Ingredient	Strength
INDINAVIR SULFATE	400 mg/1

OpenFDA Data

• SPL SET ID: 01c5574c-1056-49c6-af20-e950db3f4139
• Manufacturer:
  • Rebel Distributors Corp
• UNII:
  • 771H53976Q
• RxNorm Concept Unique ID - RxCUI:
  • 153128
  • 310988

NDC Crossover Matching brand name "CRIXIVAN" or generic name "Indinavir Sulfate"

NDC	Brand Name	Generic Name
0006-0571	CRIXIVAN	indinavir sulfate
0006-0573	CRIXIVAN	indinavir sulfate
21695-366	CRIXIVAN	indinavir sulfate
53808-0661	CRIXIVAN	indinavir sulfate